Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. - Wikidata - wikimedia - TriplyDB

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

http://www.wikidata.org/entity/Q37861313

about

Cancer stem cell metabolism Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)The Role of Infectious Agents in the Etiology of Ocular Adnexal Neoplasia Ocular adnexal lymphoma and infectious agents The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.Genome-wide DNA methylation profiles according to Chlamydophila psittaci infection and the response to doxycycline treatment in ocular adnexal lymphoma.Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution.Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma.A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci.Treatment options for ocular adnexal lymphoma (OAL).[Chlamydial diseases of the eye. A short overview]Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.Extranodal Marginal Zone B-cell Lymphoma of the Ocular Adnexa.Mitochondrial ribosomes in cancer.Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma.Update on conjunctival pathology.Unconventional therapies in ocular adnexal lymphomas.Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose.Prevalence of chlamydial infection in a series of 108 primary cutaneous lymphomas.The 2017 Doyne Lecture: the orbit as a window to systemic disease.Antibiotic use and risk of non-Hodgkin lymphomas.Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.

P2860

Q26746123-65F2DA23-1594-433B-A620-A7C102CCAE89 Q26770344-4BA34988-5ECA-48F7-8B24-26A010374BD4 Q26771654-96092823-B140-4642-8326-152B45CC7391 Q27486618-F26BDB26-A384-4796-8BB1-1A707456E029 Q27488262-BC33527A-3575-4DF5-B1F9-4C433F70208C Q30299948-D391615A-2313-4875-8747-1FE21D16F874 Q33926617-63CF7B9E-FCFD-4469-9D73-0130F1F5894D Q33982223-C26D9C65-B46C-4F40-9D27-FFA3103634A4 Q35741510-07A02916-15FC-43D6-8AFD-D6225E36C075 Q35968270-1E25F87C-3956-437B-8525-90944E3C8E34 Q35987267-8C7E1081-7A21-435D-8920-E0183B8FBD5C Q36074644-B274F750-D0D1-4487-967B-B3407CA50420 Q36544355-78FDFA8A-C7A7-419B-9045-884F6584B5AE Q36611345-9367CF08-5EF3-49DB-B943-3208A6374E3D Q36636481-5F9458F8-EECC-4D42-B96A-7CE221643A31 Q37038505-D5943F66-597A-4328-95D6-5F3F789705B1 Q37111613-BF77AA98-45DD-4AA0-AB43-F4116FDBC846 Q37396033-4F3097DA-1A43-433C-B9E0-FD67A0964E50 Q37499970-33537264-9AAA-4785-AF4C-25F84FDF8A43 Q37553676-080B29B8-44D6-49D4-A3BB-DBEB984AE674 Q37852439-74498963-2EAB-4BA0-A294-9956BFBAB75A Q37853817-10957686-6075-4B73-B154-F0E27928C339 Q37860577-A58C5422-E0DA-4837-8534-40E46EE92C5E Q37944372-2899A12A-7D97-4821-9035-E924136E74D3 Q38544142-A90F8C35-F254-434B-91A0-D89BDA579A6C Q38842920-9D463DCE-501A-4726-83D9-4C9F7FD352AC Q39264654-16BEAB2A-9A11-4BEC-8F45-33C337A2450D Q40114844-49780546-C318-4B33-BB68-77D14B0D5379 Q41691477-F8A4D7AA-CB8D-43E0-9A59-E4FEE579575A Q42367341-8C23023B-EF09-44FC-BA71-CDBB4893CD80 Q42909161-583B0F61-B498-4510-B9B5-009A48AD7A7A Q43242535-A20A7946-7D98-4011-9DFD-158AA707E18E Q43411762-02637654-6EFD-4B83-8578-6874C15C2FA9 Q44059279-20445412-5B0E-460A-8196-89A6A2C16A83 Q44956299-3017A252-9492-490D-8360-C67D3A24190B Q47119181-A6D5328D-3AE8-4D9E-A605-B75EAF7F1101 Q51605001-664E214D-86F4-47BE-A8C5-4422A99B439E Q53049966-8913CE92-5C7F-470D-9F98-3C1C33D264B6 Q55254924-0323C519-2C25-43DB-80F1-8F3880FA09D4

P2860

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

http://www.wikidata.org/entity/Q37861313

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@en

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@nl

type

label

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@en

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@nl

prefLabel

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@en

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@nl

P1433

Q37861313-61E66388-12E3-4DAA-A530-67A760790332

P1476

Q37861313-3A1D33A9-51F7-47A2-A643-436B2DA660B4

P2093

Q37861313-03268FB4-408B-4B7B-9659-E13F05C0E012

Q37861313-14788307-8ADA-45CD-B463-48A0E0DF1841

Q37861313-79554B69-3A75-4B1A-B2F9-46CB93698FF3

Q37861313-87464C06-210D-4A9C-943B-AC828C8A8CBD

Q37861313-8CE4B64F-FF31-4832-A968-5907DC80DD5B

Q37861313-AC0F2C43-E363-4BE0-9C29-55ED496FDBD0

Q37861313-B24F2F27-ABE2-4080-A012-FF24939E5D23

Q37861313-C92DDBC0-7FA4-4F27-9A84-405255F6526D

Q37861313-D7D2B8E7-D274-4392-AFE7-7CB9B68C8E4F

Q37861313-E0582AB8-EB64-47F9-AD1A-C020CA2883A7

P2860

Q37861313-09B1ECB4-8AAE-4884-96CF-CA5B6F5C046C

Q37861313-0EF757A9-65E1-4FC9-A235-93F77A01CDBA

Q37861313-10C9CD51-FA9E-414E-B036-25AD22F80899

Q37861313-2821C5D8-2FE3-4C74-A085-F4AF9F28568E

Q37861313-317954E7-4DCF-4CEE-9E95-55B62B7B5F3B

Q37861313-3C88621A-1BA2-434F-BE4B-4E25203B92B9

Q37861313-3D8A93EE-BD74-44DF-A886-3C2F32D6A10C

Q37861313-4AB8262E-A205-48D3-A833-7EB104F0B12E

Q37861313-5C401199-4FC5-4BBF-A00B-9EEC489B30DD

Q37861313-6F24C9B7-AFE6-4B4E-95E6-C338E3DAE40B

P304

Q37861313-99601D66-FB18-436C-A578-AAFB2FAA7337

P31

Q37861313-D3516D3D-214B-4C6E-9A36-7504BE32868B

P356

Q37861313-9F7A6C9D-FE9B-43A7-9645-92160C93579F

P407

Q37861313-2B35895B-0467-4E08-AC97-5FA02949FF0A

P433

Q37861313-3D6F8295-C081-43E0-B3AC-999D66070D74

P478

Q37861313-CDF4659E-9446-45F5-8E50-F944889FF85B

P50

Q37861313-268BFBDF-9DE9-491A-8B1D-176265F04563

Q37861313-2776B445-13DA-4D3F-BB90-30C0E258FAEC

Q37861313-C30715DD-3A7E-42E6-9381-68CF1C11B5A4

Q37861313-D76934CC-5406-4971-8394-0B9FD0B9DEC9

Q37861313-E0C119F0-D0C7-4F48-B253-2B8CBCB8E36B

P577

Q37861313-EDBBDA09-A1B4-45F9-9AC4-5A892EABF789

P5875

Q37861313-A5924804-7DA3-4892-AF04-79C4DCD64C8F

P698

Q37861313-9832FD43-710F-4FE4-80CF-D8C2A6CEF350

P921

Q37861313-4429D845-3AA2-474B-B6E9-2A7EAA7A080C

P356

P1433

Journal of the National Cancer Institute

P1476

Bacteria-eradicating therapy w ...... multicenter prospective trial.

@en

P2093

Andrés J M Ferreri

http://www.w3.org/2001/XMLSchema#string

Angelo Palmas

http://www.w3.org/2001/XMLSchema#string

Antonio Giordano Resti

http://www.w3.org/2001/XMLSchema#string

Carlo De Conciliis

http://www.w3.org/2001/XMLSchema#string

Elisa Pasini

http://www.w3.org/2001/XMLSchema#string

Federico Sacchetti

http://www.w3.org/2001/XMLSchema#string

Francesco Zallio

http://www.w3.org/2001/XMLSchema#string

Giuliana Muti

http://www.w3.org/2001/XMLSchema#string

Giuseppina P Dognini

http://www.w3.org/2001/XMLSchema#string

Judit Demeter

http://www.w3.org/2001/XMLSchema#string

P2860

Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

Multiple sequence alignment with hierarchical clustering

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.

Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa.

P304

1375-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ373

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Dolcetti

Letterio S. Politi

Massimo Guidoboni

Claudio Doglioni

Antonia A Lettini

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6775859

http://www.w3.org/2001/XMLSchema#string

P698

17018784

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial